Prevention and Treatment of Diabetic Late ComplicationsCarl E. Mogensen, Eberhard Standl No detailed description available for "Prevention and Treatment of Diabetic Late Complications". |
Contents
| 1 | |
| 13 | |
Epidemiology and clinical impact of diabetic late complications in NIDDM | 29 |
Microalbuminuria and diabetic renal disease | 41 |
Diabetic retinopathy | 75 |
Neuropathy | 93 |
Diabetes and heart disease | 151 |
Cerebral and peripheral vascular disease with special emphasis on the diabetic foot | 169 |
General monitoring of risk factors and late complications | 199 |
Treatment in relation to risk factors | 201 |
| 223 | |
Other editions - View all
Prevention and Treatment of Diabetic Late Complications Carl Erik Mogensen,Eberhard Standl Limited preview - 1989 |
Common terms and phrases
abnormalities albumin excretion rate aldose reductase inhibitor antihypertensive treatment associated atherosclerosis autonomic neuropathy axonal basement membrane blood glucose blood pressure capillary cardiac cardiovascular cholesterol Clin clinical neuropathy coronary artery coronary heart disease correlation CSII dependent diabetes diabetes duration diabetic complications diabetic control diabetic neuropathy diabetic patients diabetic retinopathy Diabetologia diagnosis disease in diabetes distal symmetric polyneuropathy duration of diabetes effect endothelial cells Engl function glomerular glycemic control glycosylation HbA1c hemoglobin hyperglycemia hypertension IDDM impaired incidence increased insulin kidney Lancet lesions levels lipid lipoproteins macrovascular disease metabolic microalbuminuria microaneurysms microangiopathy Mogensen mortality myelinated myo-inositol nerve conduction velocity Neurol NIDDM NIDDM patients normal onset pathogenesis peripheral nerve persistent proteinuria plasma platelet prevalence progression proliferative retinopathy protein proteinuria rats reduced renal disease retinal risk factors sensory sorbitol strict metabolic control sural nerve symptoms therapy tissue UalbV urinary albumin excretion urine vascular disease vessels µg/min